Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo - sprookjes - yvandenbroek - TriplyDB

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo

http://www.wikidata.org/entity/Q35226814

about

Expression of Epidermal c-Kit+ of Vitiligo Lesions Is Related to Responses to Excimer Laser.Gene of the month: KIT.Mutational profiling of acral melanomas in Korean populations.Subungual Amelanotic Melanoma Masquerading as Onychomycosis.

P2860

Q36094556-5AA11932-B50A-42F6-B6CC-E891FFA77368 Q38541920-63B0BE66-631D-472C-A089-B4B933F49D2C Q40443315-6AF5D186-BD77-4388-A726-D1FAEC13F023 Q54941046-637DE730-6A14-4CE0-B74B-0B828CAFD282

P2860

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo

http://www.wikidata.org/entity/Q35226814

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo

@ast

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo

@en

type

label

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo

@ast

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo

@en

prefLabel

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo

@ast

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo

@en

P1433

Q35226814-329532CC-B280-45B5-819E-C394FFF55D20

P1476

Q35226814-8558AA9E-FC2F-4E5F-BD8A-6D782EDE0ED2

P2093

Q35226814-050D1650-689E-497E-8873-D36A0BC2CB74

Q35226814-49BE807E-8C3C-4920-9B92-D7E1B7ED9910

Q35226814-602E3A6B-D606-4999-8661-D3478FC3F326

Q35226814-9CB2B167-42F1-4F16-AC3C-D97F3CCD579D

Q35226814-BD26E8C6-02FE-498F-9EDF-59B1D25D73EE

Q35226814-F600E390-66BC-4228-AD57-94B07D239425

P2860

Q35226814-020F0393-8CD4-4A18-8CDB-B6BF08FC3B65

Q35226814-12DF5312-9E3F-4146-86A3-E0CAD14AE2C4

Q35226814-1AEAB41C-5D71-4318-8C3A-2C12016619C1

Q35226814-54A8BE6E-F217-41E7-91AB-EC62B904B0DC

Q35226814-61156680-3153-4770-8BC1-2F15DDEC57DB

Q35226814-64C0440E-CD02-4142-A396-DAFEAF8A00A3

Q35226814-6F79DB14-E4D1-4392-8230-B7A42F1A1702

Q35226814-89180EF7-6D6A-4DBE-9BEA-5EF687B9C44B

Q35226814-AF954CF2-25D9-482A-A6C3-EA95EE50390A

Q35226814-B0A9E7F2-8ADA-44D4-9B67-4411617511FD

P304

Q35226814-FFB5A3B0-68A0-4923-B6B7-012AFB5C5FB5

P31

Q35226814-27A8EF9D-A5D3-4694-A096-DBDC107F30F4

Q35226814-555d357d-a91c-4b1c-9d8f-4e57f172c59a

P356

Q35226814-A21383B2-1817-4AD3-B6E2-92F40B932E1D

P433

Q35226814-7AE8C448-741D-4455-9E56-FA1439575545

P478

Q35226814-9198625D-87A6-4FDD-A49B-49ECB6721879

P577

Q35226814-146D03D8-EED5-4EAA-91FC-D07B9B0AEA42

P5875

Q35226814-D97D3CE9-279F-4E9D-825D-2F325C322DC8

P698

Q35226814-40E2D26E-E61D-41EE-820C-62F3AF1E7D7F

P932

Q35226814-2837350F-DE3D-4830-B690-7C6BDE3F09EF

P356

AD.2015.27.2.201

P1433

Annals of dermatology

P1476

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo

@en

P2093

Jee-Bum Lee

http://www.w3.org/2001/XMLSchema#string

Seong-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Seung-Chul Lee

http://www.w3.org/2001/XMLSchema#string

Sook Jung Yun

http://www.w3.org/2001/XMLSchema#string

Young Ho Won

http://www.w3.org/2001/XMLSchema#string

Young Jee Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.

A novel KIT mutation results in piebaldism with progressive depigmentation.

Prognostic and Clinicopathologic Associations of BRAF Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study.

Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients.

Somatic activation of KIT in distinct subtypes of melanoma.

BRAF and KIT somatic mutations are present in amelanotic melanoma.

Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin?

Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases.

Amelanotic acral melanomas: clinicopathological, BRAF mutation, and KIT aberration analyses.

Imatinib mesylate-induced repigmentation of vitiligo lesions in a patient with recurrent gastrointestinal stromal tumors.

P304

201-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5021/AD.2015.27.2.201

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274397324

http://www.w3.org/2001/XMLSchema#string

P698

25834362

http://www.w3.org/2001/XMLSchema#string

P932

4377412

http://www.w3.org/2001/XMLSchema#string